Our goal is to harness the power of nucleic acid therapeutics to address serious and life-threatening diseases.
We are conducting clinical trials of new potential medicines based on our Toll-like receptor and RNA-targeting technologies for people with cancer and rare diseases.
LEARN MORE ABOUT OPPORTUNITIES TO PARTICIPATE IN OUR ONGOING CLINICAL TRIALS:
